A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Lung Cancer|Renal Cancer|Adrenal Cancer
Interventions: DRUG: FPAC
Sponsor: National Cancer Institute (NCI)